Special report - The hospital of tomorrow

A fresh perspective on the future of private equity, based on the combined insights of five leading international fund managers.

Amid the cold, hard numbers of growth and the mechanics of capital and multiples, there is a driving force that is sometimes overlooked, yet is essential: the human element

This special report invites you to take a step back, understand the changes underway, and discover how private equity, far from being a mere financial engine, acts as a catalyst for economic and human transformation. Enjoy your journey to the heart of global private equity.

Under the dual pressure of aging demographics and budgetary constraints, US pension funds are significantly increasing their exposure to private equity. This asset class, long reserved for a financial elite, is becoming a central lever for financing the promises made to retirees. But at what price, and with what long-term guarantees? Europe is watching, hesitating and wondering: what if the future of pensions was played out outside listed markets?

New Mountain Capital adopts a Defensive Growth investment strategy, focusing on high-growth, non-cyclical sectors. Each year, the team identifies resilient sub-sectors, which it explores in depth through an in-house "Deep Dive Process". The firm is particularly well known in the healthcare sector, including life sciences and healthcare IT, as well as in segments at the crossroads of technology and infrastructure services.

Featured in the Vintage Altaroc Odyssey , Thoma Bravo is an American private equity firm specializing in the software sector. Founded by Carl Thoma and Orlando Bravo, it applies an approach focused on margin optimization and external growth. With more than 220 employees, including around 100 investment professionals, it has offices in San Francisco, Miami, Chicago, London, New York, and Dubai. Thoma Bravo manages more than $166 billion in assets across its various fund ranges.

Often perceived as a world reserved for insiders, private equity plays a key role in financing the real economy and driving business growth. This special report deciphers the mechanisms of private equity, from capital raising to value creation strategy. With a particular focus on funds of funds, which are genuine catalysts for diversification and access to rare opportunities, we explain how these tools enable investors to participate in high-potential entrepreneurial adventures.

The Fund manager Inflexion in several key sectors, including business services, technology, healthcare, and consumer goods. Its model is based on active support to maximize value creation through strategies such as mergers and acquisitions, international expansion, and digital transformation. With £11 billion under management and supporting 123 companies, Inflexion a diverse client base, ranging from sovereign wealth funds to entrepreneurs. Its culture, built on listening to and supporting entrepreneurs, along with its sector expertise, are key drivers of its success and global presence.

STG established STG as a leading player in the private equity sector. Under the leadership of Bill Chisholm, co-founder and Fund manager, the firm has developed a distinctive approach, grounded in rigor and sector expertise, that sets it apart in an industry known for being particularly competitive.

Specializing in B2B software and services, Hg established Hg as one of the major players in European private equity. Thanks to a highly targeted strategy and in-depth sector expertise, the firm supports technology leaders in their long-term growth.

In this special Summer 2024 feature, discover how companies are revolutionizing healthcare thanks to artificial intelligence, such as AiVF and its advances in in vitro fertilization, or Unlearn and its digital twins. Private Equity also supports players committed to a sustainable future, such as Beewise and its robotized beehive, or Marlink and its satellite telecommunications solutions. It's possible to combine performance and positive impact!

For over three decades, Nordic Capital has established itself as one of Northern Europe's most influential private equity firms. Founded in 1989, this pioneering company has distinguished itself through strong industry specialization, while maintaining an unwavering commitment to sustainable practices. Nordic Capital invests in strategic sectors such as healthcare, technology and financial services, while placing environmental, social and governance (ESG) issues at the heart of its priorities.

A major player in global private equity, Bridgepoint established Bridgepoint as the benchmark for mid-market investment. Thanks to a disciplined, sector-focused, and growth-oriented approach, the firm supports European and international companies as they scale up.

As the historic driving force behind global private equity, the United States is home to some of the most dynamic companies on the planet. This report highlights 10 hyper-growth American companies, backed by private equity, at the heart of key economic sectors.

In recent years, the alignment of interests between private companies and Private Equity players has strengthened, with the aim of achieving clean, sustainable growth. Issues such as climate change, biodiversity protection and fairness on boards of directors have become priorities for consumers and investors alike. The bottom line is clear: financial performance alone is no longer enough. Companies, particularly those backed by Private Equity funds, must at the very least take into account their impact on their ecosystem, and some even have a positive impact on the world.

New technologies are revolutionizing the healthcare sector more than ever. Artificial intelligence is now positioned as a diagnostic tool for certain cancers and cardiovascular diseases; it can also speed up clinical trials, predict potential complications linked to medical treatments and provide invaluable assistance with fertility. The managers of Vintage Altaroc have positioned themselves in this resilient, high-growth sector, which, as you will discover, offers the benefits of personalized, predictive medicine.

Competitive advantage, conquering new markets, attracting talent... innovation is more than ever a growth driver for companies.